Wellspring Wellness Group (Pty) Ltd is a South African omnichannel health-and-wellness retailer delivering premium supplements, natural foods, functional health products, clean beauty and eco-living essentials through an integrated physical-retail and e-commerce ecosystem. The Company combines high-touch, advisory-led specialty retail with a scalable digital platform, a high-margin private-label range, and a loyalty-driven recurring-revenue model, positioning it as a category-defining wellness platform rather than a conventional health-food retailer.

The Company is raising R150 million of growth capital (R90m equity / R60m senior debt) to fund its distribution hub, e-commerce and subscription platform, private-label development, and store-network expansion. On the sponsor operating case, revenue grows at 14% per annum from R650m in FY2026 to R1,098m by FY2030, with EBITDA margin expanding from 14% to 18% as the private-label and e-commerce mix deepens.

Investment highlights

• Defensive, structurally growing category: wellness and preventative-health spending is resilient and compounding at an estimated 7–10% per annum, underpinned by health awareness, chronic-lifestyle conditions and clean-label demand.
• Private label is the margin engine: own-brand supplements, protein and skincare carry 45–60% gross margins versus 25–35% for branded lines, and scaling private label from ~12% to ~20% of revenue drives the gross-margin expansion.
• Recurring, high-retention revenue: subscription wellness boxes, loyalty monetisation and B2B supply to gyms, spas and corporates create predictable, repeat cash flows.
• Capital-efficient omnichannel model: an advisory-led store format plus a mobile-first e-commerce platform with click-and-collect and same-day metro delivery, sharing unified inventory.
• Regional optionality: a Phase-3 runway into Namibia, Botswana, Zambia and Kenya provides SADC white-space beyond the domestic base.

The independent analytical view

This plan preserves the sponsor’s revenue and EBITDA but re-underwrites the earnings below EBITDA on a fully-loaded basis. The sponsor case provides EBITDA but no net-profit line; once componentised depreciation (~R35m–R38m per annum), cash interest on the R60m senior facility, and 27% corporate income tax are applied, re-underwritten net profit is R37m in FY2026 rising to R116m by FY2030, net margins of 5.6% rising to 10.6%, thin in the early rollout years and improving materially as the network matures and private label scales.

Returns summary

New equity of R90m acquires an estimated 11.4% stake at a 7.5x entry EV/EBITDA. On a five-year hold to FY2030 and an 8.0x exit multiple, the base case delivers an equity IRR of approximately 20% and a 2.4x money multiple. On a conservative flat-multiple exit (no re-rating), the IRR is still approximately 19%, a return driven by earnings growth, strong cash generation and distributions rather than multiple expansion.

Table 1.1 Headline financial summary (re-underwritten basis).

Transaction overview

Table 1.2 Indicative transaction overview.